Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Fallon Esther Chipidza, M.D.

Concepts (73)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Carcinoma, Merkel Cell120203280.530 Why?
Diagnostic Techniques and Procedures120162190.460 Why?
Lymphoma, Non-Hodgkin1202113720.450 Why?
Mastectomy2202118170.450 Why?
Anger120164060.440 Why?
Hodgkin Disease1202113780.440 Why?
Lymphoma, Large B-Cell, Diffuse1202114050.380 Why?
Prostatic Neoplasms52023111060.300 Why?
Radiotherapy, Adjuvant3202317840.290 Why?
Zimbabwe320211350.280 Why?
Skin Neoplasms1202058120.180 Why?
Breast Neoplasms32021209880.170 Why?
Botswana1202110490.150 Why?
Delivery of Health Care1201653320.150 Why?
Prostate-Specific Antigen2202324650.140 Why?
Multiple Pulmonary Nodules120181730.130 Why?
Radiation Oncology120215630.120 Why?
Retrospective Studies82023805660.100 Why?
Kaplan-Meier Estimate2202064740.100 Why?
Data Collection1202133150.100 Why?
Aggression120167500.090 Why?
Neoplasm Staging32020111160.090 Why?
Patient Compliance1202126880.090 Why?
Tumor Suppressor Protein p531202029170.090 Why?
Cancer Care Facilities220244210.080 Why?
High-Throughput Nucleotide Sequencing1202136340.080 Why?
Proportional Hazards Models22020124470.080 Why?
Radiosurgery1201713390.070 Why?
Carcinoma, Pancreatic Ductal1201817270.070 Why?
Tumor Microenvironment1202038680.070 Why?
Drug Prescriptions1201616690.070 Why?
Mutation22021300160.070 Why?
Prognosis32022296000.070 Why?
Humans1620247606170.060 Why?
Gene Expression Regulation, Neoplastic1202185420.060 Why?
Prostate2202317730.060 Why?
Neoplasms22024221310.060 Why?
Adjuvants, Pharmaceutic12023480.060 Why?
Lung Neoplasms22018133820.050 Why?
Physician-Patient Relations1201632390.050 Why?
Neoadjuvant Therapy2202328270.050 Why?
Pancreatic Neoplasms1201853670.050 Why?
Analgesics, Opioid1201638050.040 Why?
Health Services Misuse120212440.040 Why?
Carcinoma, Non-Small-Cell Lung1201753190.040 Why?
Salvage Therapy1202312630.030 Why?
Male820233603580.030 Why?
Survival Rate22021127190.030 Why?
Prostatectomy1202318240.030 Why?
SEER Program1202014500.030 Why?
Risk Assessment12016239720.030 Why?
Needs Assessment1202011390.030 Why?
Treatment Outcome12020645680.030 Why?
DNA Repair1202220430.030 Why?
Female520213921480.020 Why?
Artificial Intelligence1202425740.020 Why?
Middle Aged520212205840.020 Why?
Healthcare Disparities1202433510.020 Why?
Risk1202096040.020 Why?
Aged420201690420.020 Why?
Palliative Care1202135920.020 Why?
Neoplasm Recurrence, Local1202392770.020 Why?
Clinical Trials as Topic1202079950.010 Why?
Health Services Accessibility1202154300.010 Why?
Age Factors12020183810.010 Why?
Incidence12020213370.010 Why?
Follow-Up Studies12021390630.010 Why?
Case-Control Studies12017221480.010 Why?
Cohort Studies12020414570.010 Why?
Tomography, X-Ray Computed12018205560.010 Why?
Adult220212209690.010 Why?
Risk Factors12021741150.010 Why?
United States12020722720.010 Why?
Chipidza's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (73)
Explore
_
Co-Authors (53)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.